SBShoiab Bukhari

Shoiab Bukhari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shoiab Bukhari has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Osteoarthritis increases the risk of inflammatory arthritis due to immune checkpoint inhibitors associated with tissue-resident memory T cells

    by Matthieu Paiola, Daniel M Portnoy, Luke Yi Hao, Shoiab Bukhari, Robert J Winchester, Brian S Henick, Adam Mor, Yevgeniya Gartshteyn

    Objective: Immune checkpoint inhibitors (ICIs) have significantly advanced cancer treatment, but they can also lead to immune-related adverse events (irAEs), including inflammatory arthritis. Understanding the risk factors and underlying mechanisms of irAE pathogenesis is crucial for optimal patient management. Increasing evidence suggests that ICI-mediated activation of tissue-resident memory T cells (T RM ) significantly eliminates cancer cells and is associated with irAE-related colitis and dermatitis. However, it remains unknown why the development of these irAEs is restricted to a subset of patients. We hypothesized that osteoarthritis (OA) associated tissue damage and chronic inflammation lead to the recruitment and differentiation of joint T RM cells, predisposing individuals to ICI-induced arthritis. Methods: Using a comprehensive approach, we compared the prevalence of OA in patients with irAE-arthritis to those with irAE non-arthritis and those without irAEs. Additionally, we used advanced immunophenotyping techniques to characterize T-cell populations in the blood and synovial fluid of patients with OA and irAE-arthritis. Results: Our findings revealed a significantly higher prevalence of OA in patients who developed irAE-arthritis than controls. Furthermore, the multivariable analysis identified OA, body mass index, and smoking as independent risk factors for the development of irAE-arthritis. T RM cells expressing programmed cell death protein-1 (PD-1) were the predominant synovial T cells in OA joints. These cells were directly targeted by ICIs, resulting in an inflammatory immune response and the transition from OA to irAE-arthritis. Conclusion: This study, the first of its kind, identifies OA as a significant risk factor for irAEarthritis. It reveals a potential mechanism by which ICIs activate PD-1-positive T RM cells in OA joints, resulting in tissue inflammation and irAE-arthritis. This research could significantly enhance the management and treatment of patients with cancer receiving ICIs.


  • Open Access

    SLAMF6 compartmentalization enhances T cell functions

    by Yevgeniya Gartshteyn, Anca D Askanase, Ruijiang Song, Shoiab Bukhari, Matthew Dragovich, Kieran Adam, Adam Mor

    Signaling lymphocyte activation molecule family member 6 (SLAMF6) is a T cell co-receptor. Previously, we showed that SLAMF6 clustering was required for T cell activation. To better understand the relationship between SLAMF6 location and function and to evaluate the role of SLAMF6 as a therapeutic target, we investigated how its compartmentalization on the cell surface affects T cell functions. We used biochemical and co-culture assays to show that T cell activity is enhanced when SLAMF6 colocalizes with the CD3 complex. Mechanistically, co-immunoprecipitation analysis revealed the SLAMF6-interacting proteins to be those essential for signaling downstream of T cell receptor, suggesting the two receptors share downstream signaling pathways. Bispecific anti-CD3/SLAMF6 antibodies, designed to promote SLAMF6 clustering with CD3, enhanced T cell activation. Meanwhile, anti-CD45/SLAMF6 antibodies inhibited SLAMF6 clustering with T cell receptor, likely because of the steric hindrance, but nevertheless enhanced T cell activation. We conclude that SLAMF6 bispecific antibodies have a role in modulating T cell responses, and future work will evaluate the therapeutic potential in tumor models.


  • Lung cancer cell‐derived EDA‐containing fibronectin induces an inflammatory response from monocytes and promotes metastatic tumor microenvironment

    by Asif Amin, Taseem A. Mokhdomi, Shoiab Bukhari, Zubair Wani, Naveed A. Chikan, Basit A. Shah, Aabid M. Koul, Umer Majeed, Faizah Farooq, Ayub Qadri, et al.

    Tumor‐associated macrophages (TAMs) play a pivotal role in facilitating tumor growth and metastasis. This tumor‐promoting propensity of TAMs sets in as a result of their complex cross‐talk with tumor cells mediated primarily by tumor cell‐secreted proteins in the tumor microenvironment. To explore such interactions, we employed an immunoscreening approach involving the immunization of Balb‐c mice with model human lung carcinoma cell line, A549. From serological examination combined with mass spectrometric analysis, EDA‐containing fibronectin (EDAFN) was identified as a conspicuous immunogenic protein in A549 cell secretome. We showed that A549 secreted EDAFN engages TLR‐4 on THP‐1 monocytes to drive the proinflammatory response via NF‐κB signaling cascade. Conversely, A549 derived EDAFN potentiates their metastatic capacity by inducing epithelial–mesenchymal transition through its autocrine activity. In conclusion, the study proposes a possible mechanism of cellular cross‐talk between lung cancer cells and associated monocytes mediated by lung cancer‐derived EDAFN and resulting in the establishment of proinflammatory and metastatic tumor microenvironment.


  • Open Access

    Comparative proteomics and global genome-wide expression data implicate role of ARMC8 in lung cancer

    by Asif Amin, Shoiab Bukhari, Taseem A Mokhdomi, Naveed Anjum, Asrar H Wafai, Zubair Wani, Saima Manzoor, Aabid M Koul, Basit Amin, Qurat-Ul-Ain Qurat-Ul-Ain, et al.

    Cancer loci comprise heterogeneous cell populations with diverse cellular secretions. Therefore, disseminating cancer-specific or cancer-associated protein antigens from tissue lysates could only be marginally correct, if otherwise not validated against precise standards. In this study, 2DE proteomic profiles were examined from lysates of 13 lung-adenocarcinoma tissue samples and matched against the A549 cell line proteome. A549 matched-cancer-specific hits were analyzed and characterized by MALDI-TOF/MS. Comparative analysis identified a total of 13 protein spots with differential expression. These proteins were found to be involved in critical cellular functions regulating pyrimidine metabolism, pentose phosphate pathway and integrin signaling. Gene ontology based analysis classified majority of protein hits responsible for metabolic processes. Among these, only a single non-predictive protein spot was found to be a cancer cell specific hit, identified as Armadillo repeat-containing protein 8 (ARMC8). Pathway reconstruction studies showed that ARMC8 lies at the centre of cancer metabolic pathways. The findings in this report are suggestive of a regulatory role of ARMC8 in control of proliferation and differentiation in lung adenocarcinomas.


  • Relative expression of apocarotenoid biosynthetic genes in developing stigmas of Crocus sativus L.

    by Javid IqbaLMzr, Nazeer Ahmed, Tassem Ahmad Mokhdomi, Asrar Hussain Wafai, Sajad Hassan Wani, Shoiab Bukhari, Asif Amin, Raies Ahmad Qadri


  • Investigating the pharmacological potential of Iris kashmiriana in limiting growth of epithelial tumors

    by Asif Amin, Sajad H. Wani, Taseem A. Mokhdomi, Shoiab Bukhari, Asrar H. Wafai, Javid Iqbal Mir, Qazi Parvaiz Hassan, Raies A. Qadri